Q3 2022 Holdings
Filed 2022-11-14 | 38 holdings | $127.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | Common | 230031106 | $98.1M | 7,648,268 | 76.7% |
| Cytokinetics Inc.(CYTK) | Common | 23282W605 | $9.4M | 193,205 | 7.3% |
| Biocryst Pharmaceuticals Inc.(BCRX) | Common | 09058V103 | $7.6M | 605,663 | 6.0% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $7.2M | 364,710 | 5.6% |
| Arcutis Biotherapeutics inc(ARQT) | Common | 03969K108 | $4.9M | 257,185 | 3.8% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $405.0K | 239,888 | 0.3% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $33.3K | 1,745,943 | 0.0% |
| Inhibrx, Inc(INBXUSD) | Common | 45720L107 | $23.0K | 1,279,995 | 0.0% |
| Verve Therapeutics, Inc | Common | 92539P101 | $21.8K | 635,792 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $21.0K | 374,409 | 0.0% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $19.9K | 1,639,849 | 0.0% |
| Geron Corporation(GERN) | Common | 374163103 | $19.7K | 8,422,582 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | Common | 46583P102 | $18.8K | 1,050,000 | 0.0% |
| Merus N.V. | Common | N5749R100 | $18.4K | 918,310 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $16.4K | 619,083 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $16.3K | 1,700,000 | 0.0% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $10.8K | 2,388,011 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $10.7K | 856,798 | 0.0% |
| Travere Therapeutics Inc.(TVTX) | Common | 89422G107 | $6.8K | 276,460 | 0.0% |
| Y Mabs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $6.4K | 443,702 | 0.0% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $6.1K | 3,370,982 | 0.0% |
| Harmony Biosciences Hldgs Inc.(HRMY) | Common | 413197104 | $6.1K | 136,780 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | Common | 75615P103 | $4.5K | 179,058 | 0.0% |
| Amicus Therapeutics Inc.(FOLD) | Common | 03152W109 | $4.1K | 392,946 | 0.0% |
| Provention Bio Inc(PRVBUSD) | Common | 74374N102 | $3.3K | 740,344 | 0.0% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $3.1K | 3,196,707 | 0.0% |
| Edgewise Therapeutics, Inc.(EWTX) | Common | 28036F105 | $3.0K | 304,027 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $2.9K | 44,747 | 0.0% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $2.9K | 146,041 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $2.8K | 3,244,650 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | Common | 71722W107 | $2.1K | 193,326 | 0.0% |
| Avadel Pharmaceuticals Plc | Common | 05337M104 | $2.1K | 412,363 | 0.0% |
| Mirum Pharmaceuticals Inc.(MIRM) | Common | 604749101 | $2.0K | 97,322 | 0.0% |
| Oncorus, Inc. | Common | 68236R103 | $2.0K | 2,377,031 | 0.0% |
| Inozyme Pharma Inc. | Common | 45790W108 | $1.8K | 661,144 | 0.0% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $1.6K | 334,384 | 0.0% |
| Essa Pharma, Inc.(EPIEUR) | Common | 29668H708 | $738 | 405,700 | 0.0% |
| Avrobio, Inc. | Common | 05455M100 | $416 | 647,918 | 0.0% |